These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26216582)

  • 1. Prevalence of MRSA and Gram-negative bacteria with ESBLs and carbapenemases in patients from Northern Africa at a German hospital.
    Leistner R; Denkel LA; Gastmeier P; Werner G; Layer F; Pfeifer Y
    J Antimicrob Chemother; 2015 Nov; 70(11):3161-4. PubMed ID: 26216582
    [No Abstract]   [Full Text] [Related]  

  • 2. The emerging threat of acquired carbapenemases in Gram-negative bacteria.
    Cornaglia G; Rossolini GM
    Clin Microbiol Infect; 2010 Feb; 16(2):99-101. PubMed ID: 20085603
    [No Abstract]   [Full Text] [Related]  

  • 3. Faecal carriage of ESBL-producing Enterobacteriaceae and carbapenem-resistant Gram-negative bacilli in community settings.
    Villar HE; Baserni MN; Jugo MB
    J Infect Dev Ctries; 2013 Aug; 7(8):630-4. PubMed ID: 23949299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with recovery of multidrug-resistant bacteria in a combat support hospital in Iraq.
    Aldous WK; Co EM
    Infect Control Hosp Epidemiol; 2010 Apr; 31(4):425-7. PubMed ID: 20184421
    [No Abstract]   [Full Text] [Related]  

  • 5. Carbapenemases: a brief review for pediatric infectious disease specialists.
    Overturf GD
    Pediatr Infect Dis J; 2010 Jan; 29(1):68-70. PubMed ID: 20035208
    [No Abstract]   [Full Text] [Related]  

  • 6. Emerging carbapenemases: a global perspective.
    Walsh TR
    Int J Antimicrob Agents; 2010 Nov; 36 Suppl 3():S8-14. PubMed ID: 21129630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired metallo-beta-lactamases: an increasing clinical threat.
    Rossolini GM
    Clin Infect Dis; 2005 Dec; 41(11):1557-8. PubMed ID: 16267726
    [No Abstract]   [Full Text] [Related]  

  • 8. NDM carbapenemases in the United Kingdom: an analysis of the first 250 cases.
    Jain A; Hopkins KL; Turton J; Doumith M; Hill R; Loy R; Meunier D; Pike R; Livermore DM; Woodford N
    J Antimicrob Chemother; 2014 Jul; 69(7):1777-84. PubMed ID: 24769387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of infections caused by multiresistant gram-negatives: ESBLs, MBLs, panresistant strains.
    Rossolini GM; Mantengoli E; Docquier JD; Musmanno RA; Coratza G
    New Microbiol; 2007 Jul; 30(3):332-9. PubMed ID: 17802921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbapenem-resistant Gram-negative bacilli in Canada 2009-10: results from the Canadian Nosocomial Infection Surveillance Program (CNISP).
    Mataseje LF; Bryce E; Roscoe D; Boyd DA; Embree J; Gravel D; Katz K; Kibsey P; Kuhn M; Mounchili A; Simor A; Taylor G; Thomas E; Turgeon N; Mulvey MR;
    J Antimicrob Chemother; 2012 Jun; 67(6):1359-67. PubMed ID: 22398651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of carbapenemases in Gram-negative bacteria in Hamburg, Germany.
    Hentschke M; Goritzka V; Campos CB; Merkel P; Ilchmann C; Lellek H; Scherpe S; Aepfelbacher M; Rohde H
    Diagn Microbiol Infect Dis; 2011 Nov; 71(3):312-5. PubMed ID: 21899979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug-resistant Gram-negative bacteria: a product of globalization.
    Hawkey PM
    J Hosp Infect; 2015 Apr; 89(4):241-7. PubMed ID: 25737092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of New Delhi metallo-β-lactamase (NDM-1)-positive bacteria in a tertiary care centre in Pune, India.
    Bharadwaj R; Joshi S; Dohe V; Gaikwad V; Kulkarni G; Shouche Y
    Int J Antimicrob Agents; 2012 Mar; 39(3):265-6. PubMed ID: 22137509
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of the Blue-Carba test for rapid detection of carbapenemases in gram-negative bacilli.
    Pasteran F; Veliz O; Ceriana P; Lucero C; Rapoport M; Albornoz E; Gomez S; Corso A;
    J Clin Microbiol; 2015 Jun; 53(6):1996-8. PubMed ID: 25809971
    [No Abstract]   [Full Text] [Related]  

  • 15. Trends in antimicrobial non-susceptibility in methicillin-resistant Staphylococcus aureus from Germany (2004-2011).
    Schaumburg F; Idelevich EA; Peters G; Mellmann A; von Eiff C; Becker K;
    Clin Microbiol Infect; 2014 Sep; 20(9):O554-7. PubMed ID: 24372797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of co-expression of newer beta-lactamases (ESBLs, Amp-C-beta-lactamases, and metallo-beta-lactamases) in gram-negative bacilli.
    Chatterjee SS; Karmacharya R; Madhup SK; Gautam V; Das A; Ray P
    Indian J Med Microbiol; 2010; 28(3):267-8. PubMed ID: 20644325
    [No Abstract]   [Full Text] [Related]  

  • 17. Characteristics, epidemiology and clinical importance of emerging strains of Gram-negative bacilli producing extended-spectrum beta-lactamases.
    Shah AA; Hasan F; Ahmed S; Hameed A
    Res Microbiol; 2004; 155(6):409-21. PubMed ID: 15249058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characteristics of community-acquired methicillin-resistant Staphylococcus aureus in Hokkaido, northern main island of Japan: identification of sequence types 6 and 59 Panton-Valentine leucocidin-positive community-acquired methicillin-resistant Staphylococcus aureus.
    Kawaguchiya M; Urushibara N; Kuwahara O; Ito M; Mise K; Kobayashi N
    Microb Drug Resist; 2011 Jun; 17(2):241-50. PubMed ID: 21395449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissemination of IncF plasmids carrying beta-lactamase genes in Gram-negative bacteria from Nigerian hospitals.
    Ogbolu DO; Daini OA; Ogunledun A; Terry Alli OA; Webber MA
    J Infect Dev Ctries; 2013 May; 7(5):382-90. PubMed ID: 23669427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etiology, extended-spectrum β-lactamase rates and antimicrobial susceptibility of gram-negative bacilli causing intra-abdominal infections in patients in general pediatric and pediatric intensive care units--global data from the Study for Monitoring Antimicrobial Resistance Trends 2008 to 2010.
    Badal RE; Bouchillon SK; Lob SH; Hackel MA; Hawser SP; Hoban DJ
    Pediatr Infect Dis J; 2013 Jun; 32(6):636-40. PubMed ID: 23838732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.